Department of Radiology, Stanford University School of Medicine, 300 Pasteur Drive, Suite H1330, Stanford, CA 94305, USA.
Dean's Office, Otago Medical School, University of Otago, Dunedin 9016, New Zealand; Department of Radiology, Duke University, Durham, NC 27705, USA.
PET Clin. 2022 Apr;17(2):319-326. doi: 10.1016/j.cpet.2021.12.001. Epub 2022 Mar 4.
PET/computed tomography (CT) is a valuable tool in post-therapy follow-up of head and neck cancers. PET/CT is sensitive and specific, can detect recurrences that otherwise may be missed on routine clinical examination or conventional imaging, and also can have an impact on patient management. National Comprehensive Cancer Network guidelines recommend PET/CT be performed within 3 months to 6 months after therapy. After this baseline scan, however, further routine PET/CT surveillance in asymptomatic patients has unclear benefit. Additional post-therapy PET/CT imaging should be individualized to patients based on considerations such as tumor type, stage, prognostic factors, symptoms, and clinical assessment.
正电子发射断层显像/计算机断层扫描(PET/CT)是头颈部癌症治疗后随访的一项重要工具。PET/CT敏感且具有特异性,能够检测出常规临床检查或传统影像学检查可能遗漏的复发情况,并且还会对患者的治疗管理产生影响。美国国立综合癌症网络指南建议在治疗后3至6个月内进行PET/CT检查。然而,在进行此次基线扫描后,对无症状患者进行进一步的常规PET/CT监测的获益并不明确。治疗后的PET/CT额外成像应根据肿瘤类型、分期、预后因素、症状及临床评估等因素对患者进行个体化安排。